Embedded Files
Our vision is to cure all children with high-risk neuroblastoma using novel precision therapies developed by our expert network of laboratory and clinical investigators.
NANT is an established international collaboration between neuroblastoma experts in children's cancer centers across North America, Europe and Australia.
We’re discovering why neuroblastoma outsmarts today’s treatments and then using that knowledge to design the next generation of therapies.
NANT is the only consortium solely dedicated to early phase trials of new treatments for relapsed/refractory high-risk neuroblastoma for over 25 years.
Currently Open Trials:
Google Sites
Report abuse